ArticleCancer immunology, immunotherapy : CII2025

Impact of rheumatoid factors on the function of therapeutic monoclonals specific for PD-1/PD-L1.

Barry D Hock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.